Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

C3_RECTUM_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C20 Hospital discharge: ICD-9 — 154 Hospital discharge: ICD-8 — 1541 Cause of death: ICD-10 — C20 Cause of death: ICD-9 — 154 Cause of death: ICD-8 — 1541 Cause of death: excluded ICD-9 — 1540\|154[2-3] Cancer registry: Topography ICD-O-3 — C20 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	4994
4. Check minimum number of events None	4994
5. Include endpoints None	4994
6. Filter based on genotype QC (FinnGen only)	4994

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_RECTUM_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C20
HD_ICD_9	154
HD_ICD_8	1541
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C20
COD_ICD_9	154
COD_ICD_8	1541
COD_ICD_10_EXCL
COD_ICD_9_EXCL	1540\|154[2-3]
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C20
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4994	1923	3071
Unadjusted period prevalence (%)	1.08	0.66	1.35
Median age at first event (years)	67.73	66.05	68.79

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3318: Matched controls
33176

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

1758

JG1BG

NOMESCO Finland

MRI of rectum

804.2

323.0

541

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

973.3

323.0

567

TJF80

NOMESCO Finland

Ostomy education

203.1

323.0

441

B01AB05

ATC

enoxaparin; parenteral

5.2

323.0

1752

5881

H02AB02

ATC

dexamethasone; systemic

109.9

323.0

889

110

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

323.0

397

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

5435.5

323.0

479

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

323.0

450

WX408

NOMESCO Finland

General anesthesy, balanced

4.9

323.0

1454

4594

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

323.0

590

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

24.8

323.0

550

264

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

130.6

323.0

442

JG1CG

NOMESCO Finland

Extensive MRI of rectum

734.5

323.0

447

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

27.8

323.0

1653

1143

JFF23

NOMESCO Finland

Transversostomy

266.4

323.0

696

WZC30

NOMESCO Finland

Teaching

7.6

323.0

892

1534

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

5.6

323.0

1561

4563

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

323.0

402

JN4BD

NOMESCO Finland

Extensive body CT

23.0

323.0

1191

786

WX302

NOMESCO Finland

Thoracal epidural anesthesy

54.8

323.0

1025

268

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

499.4

323.0

359

A04AA02

ATC

granisetron; systemic, transdermal

2768.2

323.0

787

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

19.4

323.0

864

592

XX3DW

NOMESCO Finland

Time consuming IT work

14.5

323.0

759

665

UJF32

NOMESCO Finland

Coloscopy

11.4

323.0

2247

5152

JN4AD

NOMESCO Finland

Body CT examination

17.4

323.0

688

490

L01BC06

ATC

capecitabine; oral

+∞

323.0

1426

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

323.0

2885

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

679.7

323.0

418

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

369.3

323.0

388

A03FA01

ATC

metoclopramide; systemic, rectal

16.2

323.0

1657

1926

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

39.0

323.0

564

173

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

6316.8

323.0

543

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

323.0

800

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

323.0

369

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

323.0

338

Z93.3

ICD-10 Finland

Colostomy status

158.7

323.0

441

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

323.0

2836

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

1976.6

323.0

340

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

323.0

503

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

655.2

323.0

353

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

323.0

788

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

9573.1

323.0

1598

D75

ICPC

Malignant neoplasm colon/rectum

3897.0

323.0

360

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

284.7

323.0

625

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

3167.0

315.4

300

UJG02

NOMESCO Finland

Proctoscopy

26.2

310.5

441

193

C61

ICD-10 Finland

Malignant neoplasm of prostate

278.8

278.4

281

WF002

NOMESCO Finland

Radical radiotherapy

229.5

268.3

274

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2626.7

266.0

254

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

198.9

265.8

274

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

263.0

249

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

253.4

240

ZX090

NOMESCO Finland

Other technic of radiotherapy

525.9

249.0

245

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

1268.1

244.7

236

JN4CD

NOMESCO Finland

Very extensive body CT

20.9

237.9

362

193

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

232.0

220

WX600

NOMESCO Finland

Single shot through catheter

59.8

229.2

270

A04AA01

ATC

ondansetron; systemic, rectal

17.6

226.5

367

233

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

168.4

224.9

235

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

137.8

217.4

231

Z51.5

ICD-10 Finland

Palliative care

13.3

217.2

396

334

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

1113.0

216.0

209

WF049

NOMESCO Finland

Radiotherapy of metastasis

1090.3

211.7

205

N02AA05

ATC

oxycodone; systemic

4.8

209.9

807

2078

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

688.1

199.3

195

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

193.6

184

ZXC96

NOMESCO Finland

Robot assisted procedure

43.6

191.4

239

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

390.6

186.6

186

TPH07

NOMESCO Finland

Cathetrisation of artery

5.0

185.9

673

1604

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

381.6

182.4

182

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

8.5

181.4

422

559

JFF10

NOMESCO Finland

Loop enterostomy

180.0

179.7

187

WF003

NOMESCO Finland

Adjuvant radiotherapy

464.4

178.7

177

WX402

NOMESCO Finland

General anaesthesia

4.4

174.5

735

2032

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

357.0

170.9

171

B01AB10

ATC

tinzaparin; parenteral

7.2

160.9

418

651

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

9.8

160.1

340

382

WF004

NOMESCO Finland

Palliative radiotherapy

1633.3

157.5

152

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

154.4

147

SPAT1125

SPAT

Stoma care and guidance

16.7

150.8

248

160

116

Kela drug reimbursment

Prostate cancer

+∞

146.9

140

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

250.6

141.3

144

A04AA55

ATC

palonosetron, combinations; systemic

+∞

135.3

129

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

101.0

132.2

145

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.0

125.2

237

211

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

124.7

119

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

123.7

118

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

69.4

121.7

140

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

5.7

120.9

374

723

A04AD12

ATC

aprepitant; systemic

1210.7

120.6

117

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.9

119.5

552

1610

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

+∞

118.4

113

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

118.4

113

Z93

ICD-10 Finland

Artificial opening status

159.5

117.0

123

ZX120

NOMESCO Finland

Intravenous

4.4

114.4

451

1133

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

550.3

108.4

107

Z51.0

ICD-10 Finland

Radiotherapy session

539.6

106.3

105

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

5.0

105.6

367

806

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

10.7

105.0

210

208

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

103.7

SPAT1262

SPAT

Handing over of treatment supplies

2.6

101.9

894

4058

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

1018.4

101.7

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

101.6

TQW40

NOMESCO Finland

Remowal of suture of skin

4.6

100.8

378

898

115

Kela drug reimbursment

Breast cancer

+∞

100.5

JGB36

NOMESCO Finland

Wide excision of rectum

+∞

100.5

WW500

NOMESCO Finland

Blood transfusion

9.1

97.6

213

247

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

95.2

L01BC59

ATC

trifluridine, combinations; systemic

+∞

95.2

JN3AD

NOMESCO Finland

Abdominal CT examination

4.1

93.8

402

1083

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

23.2

93.4

136

369

Kela drug reimbursment

Regorafenib

+∞

93.1

Z43.3

ICD-10 Finland

Attention to colostomy

114.5

92.4

100

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.4

91.3

500

1648

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

9.8

90.9

190

204

PJA12

NOMESCO Finland

Sentinel node biopsy

314.2

90.2

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

90.0

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

90.0

A79

ICPC

Malignancy NOS

236.3

89.9

L03AA13

ATC

pegfilgrastim; parenteral

891.4

89.1

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

88.9

D18

ICPC

Change in faeces/bowel movements

8.8

88.8

198

238

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

5.2

88.6

292

601

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.5

88.5

336

804

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

86.8

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

83.7

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

16.7

82.9

135

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

82.1

825

3963

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

81.6

WX306

NOMESCO Finland

Lumbar epidural anesthesy

5.6

81.3

252

482

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

79.5

JF2AB

NOMESCO Finland

Colongraphy with X-ray

56.8

79.4

JAH00

NOMESCO Finland

Laparotomy

7.9

79.1

188

250

R4110

NOMESCO Finland

Physiotherapy

2.3

79.1

972

5141

176

Kela drug reimbursment

Regorafenib

+∞

78.4

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

141.8

78.3

L02AE02

ATC

leuprorelin; implant, parenteral

44.8

77.8

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

765.3

76.6

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

163.8

76.4

N02BE01

ATC

paracetamol; systemic, rectal

2.4

76.3

2819

23404

1XC07

NOMESCO Finland

+∞

75.3

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

32.5

74.0

L03AA02

ATC

filgrastim; parenteral

71.6

73.6

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

733.9

73.4

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

72.1

Z43.2

ICD-10 Finland

Attention to ileostomy

364.9

71.9

D99

ICPC

Disease digestive system other

13.3

70.6

126

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

70.0

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

26.7

68.9

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

63.0

68.8

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

54.6

67.2

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

671.2

67.2

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

34.3

66.7

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

5.9

65.9

193

343

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

65.8

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

92.0

65.1

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

56.2

65.1

JFB00

NOMESCO Finland

Partial resection of small intestine

10.4

64.3

129

128

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.7

64.3

194

358

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

323.0

63.6

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

35.0

63.1

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

+∞

61.6

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

598.4

59.9

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

8.6

59.8

134

162

Y77

ICPC

Malignant neoplasm prostate

307.7

59.5

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

37.0

59.3

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

74.9

58.2

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

39.3

57.7

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

57.4

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

296.9

57.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.4

57.3

157

256

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

20.0

56.7

L02BB03

ATC

bicalutamide; oral

546.6

54.7

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

53.7

445

1880

XX1AD

NOMESCO Finland

Other CT-examination

275.3

53.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

53.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

53.3

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

14.4

53.0

L01XE21

ATC

[U] regorafenib; oral

+∞

52.2

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

10.6

52.0

103

100

R4190

NOMESCO Finland

Nutritional therapy

6.9

51.1

131

195

L02BG04

ATC

letrozole; oral

54.5

49.7

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

494.9

49.5

K56.7

ICD-10 Finland

Ileus, unspecified

7.3

49.2

122

173

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

484.6

48.5

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

6.8

48.1

125

190

ZZR00

NOMESCO Finland

Flap of skin

12.8

47.2

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

47.0

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

60.9

46.4

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

45.9

Z93.2

ICD-10 Finland

Ileostomy status

26.7

45.6

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

36.8

45.4

JFF24

NOMESCO Finland

Laparoscopic transversostomy

453.6

45.3

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

453.6

45.3

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

6.3

45.2

124

203

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

443.3

44.3

HAC20

NOMESCO Finland

Total mastectomy

227.9

44.0

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.1

43.7

144

294

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

29.5

43.1

E0000UV

ATC

1.7

43.0

1182

8048

N03AX16

ATC

pregabalin; oral

1.9

42.6

771

4576

JFF26

NOMESCO Finland

Sigmoidostomy

62.1

42.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

42.1

570

3028

UJF30

NOMESCO Finland

Ileoscopy through colon

2.5

42.0

346

1450

6435

FHL

Abdominoperineal resection and colostomy

114.0

41.8

B01AB04

ATC

dalteparin; parenteral

3.3

41.8

220

690

V03AF03

ATC

calcium folinate; systemic

+∞

41.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.5

39.7

196

585

JG001

NOMESCO Finland

Preopertaive radiotherapy of rectum

+∞

39.6

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

39.6

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

138.3

38.8

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.5

38.8

188

553

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.0

38.6

160

412

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

5.9

38.4

110

191

NK6AN

NOMESCO Finland

Total body bone isotope imaging

23.8

37.9

JAH01

NOMESCO Finland

Laparoscopy

4.4

37.1

139

325

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.9

36.8

238

861

8070/3-C20.9

ICD-O-3

Squamous cell carcinoma, NOS, of rectum, NOS

+∞

36.5

L01BC53

ATC

tegafur, combinations; systemic

+∞

36.5

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

21.5

36.1

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

361.0

36.0

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

35.5

8000/3-C20.9

ICD-O-3

Neoplasm, malignant of rectum, NOS

+∞

35.5

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

35.3

817

5211

S18

ICPC

Laceration/cut

1.6

35.2

1304

9502

WX704

NOMESCO Finland

Intubation

2.7

35.0

252

974

XJG12

NOMESCO Finland

Transrectal endoscopic ultrasonography

35.0

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

34.4

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

34.4

D70.82

ICD-10 Finland

Drug-induced neutropenia

18.5

34.4

A06AH03

ATC

naloxegol; oral

17.9

34.0

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

340.5

34.0

KCC10

NOMESCO Finland

Cystoprostatectomy

340.5

34.0

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

33.4

JJB30

NOMESCO Finland

Excision of two segments of liver

+∞

33.4

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

33.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

33.3

1386

10350

L02BA01

ATC

tamoxifen; oral

56.3

33.2

J01MA12

ATC

levofloxacin; systemic

1.8

32.9

606

3579

R50.9

ICD-10 Finland

Fever, unspecified

2.1

32.8

420

2162

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

14.7

32.7

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

117.8

32.7

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

49.3

32.5

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

7.3

32.5

110

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

17.2

32.3

6434

FHL

Anterior resection

54.8

32.3

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

19.1

32.2

JFB30

NOMESCO Finland

Right hemicolectomy

12.0

32.1

K92.1

ICD-10 Finland

Melaena

2.7

32.0

237

930

Z31.5

ICD-10 Finland

Genetic counselling

4.6

31.9

113

250

D01.2

ICD-10 Finland

Carcinoma in situ: Rectum

319.9

31.9

C209

ICD-10 Finland

+∞

31.3

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.7

31.2

140

387

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

60.6

31.1

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

19.0

30.9

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

315.6

30.9

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.2

30.7

138

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

111.0

30.7

G04BE03

ATC

sildenafil; oral

14.3

30.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.8

30.4

132

355

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

30.2

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

30.2

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

30.2

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

305.0

29.8

D77

ICPC

Malignant digestive neopl other/NOS

305.0

29.8

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4.3

29.7

114

274

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

12.2

29.7

HAB40

NOMESCO Finland

Wedge excision of mammary gland

17.3

29.2

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

29.2

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

29.2

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

29.2

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

29.2

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

29.2

D16

ICPC

Rectal bleeding

4.4

28.6

107

251

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

15.3

28.6

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.5

28.4

140

418

KCD02

NOMESCO Finland

Transurethral resection of bladder

16.9

28.4

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

21.8

28.2

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

28.2

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.3

28.1

106

251

A02BC02

ATC

pantoprazole; systemic

1.5

27.8

1950

16150

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

283.7

27.8

JJB71

NOMESCO Finland

Laparoscopic resection of liver

283.7

27.8

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

146.2

27.7

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

6.9

27.5

101

ZX121

NOMESCO Finland

Central venous catheter

35.3

27.4

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

5.3

27.3

164

P01AB01

ATC

metronidazole; oral, rectal

1.6

27.3

1072

7787

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

27.1

263

1192

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

+∞

27.1

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

27.1

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

5.0

27.1

183

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

7.6

26.8

C50.99

ICD-10 Finland

Breast, unspecified

273.1

26.7

LEC00

NOMESCO Finland

Partial excision of vagina

97.5

26.7

SPAT1153

SPAT

Removal of sutures

1.6

26.5

974

6950

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.0

26.2

158

546

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

26.1

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

26.1

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

26.1

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

31.2

25.9

L03AA14

ATC

lipegfilgrastim; parenteral

262.5

25.7

WX110

NOMESCO Finland

Local anesthesy

1.5

25.5

1835

15141

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.8

25.2

184

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

17.9

25.2

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

25.0

JG1BM

NOMESCO Finland

MRI of rectum (more than 1.5 T)

+∞

25.0

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

25.0

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

25.0

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

25.0

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

58.4

25.0

JEA00

NOMESCO Finland

Appendectomy

2.6

24.5

181

710

A06AD11

ATC

lactulose; oral

1.8

24.3

506

3082

JHA00

NOMESCO Finland

Anal or perianal incision

6.0

24.0

114

15411

ICD-8 Finland

Malignant neoplasm of rectum and rectosigmoid junction, Rectum

+∞

24.0

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

24.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

24.0

200

838

TJG20

NOMESCO Finland

Transanal irrigation

25.6

23.9

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

3.7

23.8

106

292

JFF30

NOMESCO Finland

Other colostomy

67.9

23.8

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

125.9

23.6

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

23.5

248

1167

J01MA02

ATC

ciprofloxacin; systemic

1.5

23.5

1189

9064

TPX15

NOMESCO Finland

Removal of vascular injection port

21.4

23.4

UKC02

NOMESCO Finland

Cystoscopy

1.7

23.3

532

3328

JFB20

NOMESCO Finland

Ileocaecal resection

17.3

23.1

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

+∞

22.9

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

22.9

1541X

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,EI HISTOLOGISTA VAHVISTUSTA]

+∞

22.9

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

22.9

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

22.9

541

3417

Z71.8

ICD-10 Finland

Other specified counselling

1.6

22.8

620

4070

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

15.6

22.8

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

40.3

22.6

C50

ICD-10 Finland

Malignant neoplasm of breast

231.4

22.6

D28

ICPC

Limited function/disability (D)

17.7

22.6

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.6

22.6

119

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

10.1

22.3

HA1AA

NOMESCO Finland

X-ray mammography

3.7

22.2

269

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

52.3

22.1

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

21.9

8210/3-C20.9

ICD-O-3

Adenocarcinoma in adenomatous polyp of rectum, NOS

+∞

21.9

WX882

NOMESCO Finland

High dependency care

3.5

21.8

105

309

ZX112

NOMESCO Finland

Subcutaneous

7.8

21.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

21.6

170

690

ZX050

NOMESCO Finland

Stereotactic radiotherapy

43.6

21.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

21.0

245

1207

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

20.9

225

1067

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

16.6

20.9

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

20.8

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

+∞

20.8

8144/3-C20.9

ICD-O-3

Adenocarcinoma, intestinal type of rectum, NOS

+∞

20.8

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

20.8

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

+∞

20.8

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

6.1

20.8

JAG43

NOMESCO Finland

Repair of stomal hernia with mesh

211.2

20.6

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

211.2

20.6

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.1

20.6

129

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

110.7

20.6

NET99

NOMESCO Finland

Other operation on pelvis

110.7

20.6

KC1GB

NOMESCO Finland

Cystography with X-ray

30.2

20.5

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

9.4

20.5

ZZR10

NOMESCO Finland

Flap of skin and muscle

20.2

20.3

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

5.3

20.2

119

T81.9

ICD-10 Finland

Unspecified complication of procedure

4.4

20.2

167

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

20.2

357

2055

UJH02

NOMESCO Finland

Anoscopy

2.7

20.1

144

555

R33

ICD-10 Finland

Retention of urine

1.9

19.8

307

1690

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

19.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

19.8

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

19.8

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

19.8

1XC08

NOMESCO Finland

+∞

19.8

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

19.8

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

19.8

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

19.8

L02BX02

ATC

degarelix; parenteral

+∞

19.8

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

19.8

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

19.8

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

73.9

19.7

K45.0

ICD-10 Finland

Other specified abdominal hernia with obstruction, without gangrene

31.5

19.2

D29

ICPC

Digestive symptom/complaint other

4.0

19.2

195

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.2

19.2

114

G04CA02

ATC

tamsulosin; oral

1.5

19.0

917

6849

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

6.5

19.0

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

18.8

X76

ICPC

Malignant neoplasm breast female

+∞

18.8

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

17.2

18.7

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

190.9

18.5

D17

ICPC

Incontinence of bowel

6.2

18.3

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

5.2

18.3

112

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.8

18.0

207

JAD10

NOMESCO Finland

Repair of incisional hernia

6.6

17.9

LCD00

NOMESCO Finland

Hysterectomy

2.8

17.9

114

410

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

17.9

222

1123

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

18.1

17.8

GDC00

NOMESCO Finland

Lobectomy of lung

22.9

17.7

128

Kela drug reimbursment

Cancers of female genital organs

+∞

17.7

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

17.7

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.4

17.7

257

GDB10

NOMESCO Finland

Wedge resection of lung

36.9

17.6

XKD00

NOMESCO Finland

Uroflowmetry

1.6

17.4

521

3485

UJF34

NOMESCO Finland

Left colonoscopy

6.9

17.4

R19.4

ICD-10 Finland

Change in bowel habit

3.1

17.3

305

SPAT1109

SPAT

Analgesia with portable analgesic pump

13.9

17.2

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

14.8

17.1

N82.3

ICD-10 Finland

Fistula of vagina to large intestine

25.7

16.9

WX002

NOMESCO Finland

Sedation and analgesia

1.5

16.8

570

3929

K61.1

ICD-10 Finland

Rectal abscess

11.2

16.7

LEE10

NOMESCO Finland

Repair of vagina using graft or flap

+∞

16.7

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

16.7

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

16.7

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

16.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

16.6

237

1264

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

16.6

420

2688

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

90.5

16.6

N02AX02

ATC

tramadol; systemic, rectal

1.4

16.5

1234

9943

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

170.7

16.5

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

12.2

16.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

16.3

884

6724

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

5.8

16.1

JGA75

NOMESCO Finland

Endoscopic microsurgical excision of lesion of rectum

30.2

16.1

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

16.0

515

7129

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

16.0

147

651

JKA20

NOMESCO Finland

Cholecystectomy

2.7

16.0

107

398

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

60.3

15.8

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

33.5

15.7

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

15.6

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

15.6

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

15.6

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

15.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

15.6

K62.7

ICD-10 Finland

Radiation proctitis

+∞

15.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

85.5

15.6

JGA98

NOMESCO Finland

Other transluminal endoscopic local operation on rectum

22.1

15.5

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.5

15.5

125

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

3.9

15.5

168

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

160.6

15.5

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

160.6

15.5

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

160.6

15.5

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.5

15.4

K56.0

ICD-10 Finland

Paralytic ileus

4.6

15.1

115

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

6.3

15.0

K62.1

ICD-10 Finland

Rectal polyp

4.7

14.9

108

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

14.6

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

14.6

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

10.9

14.5

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

36.2

14.4

R11

ICD-10 Finland

Nausea and vomiting

1.9

14.4

207

1106

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

11.4

14.3

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

42.6

14.1

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

14.1

120

513

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

14.5

14.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

13.9

384

2507

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

13.9

509

6908

WX892

NOMESCO Finland

Monitored bed care

1.8

13.8

229

1287

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

13.8

430

2898

JAG96

NOMESCO Finland

Other reconstruction of abdominal wall

20.1

13.8

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.3

13.7

A28

ICPC

Limited function/disability NOS

1.5

13.7

491

3417

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

75.4

13.6

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

13.5

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

13.5

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

13.5

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

13.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

13.5

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

13.5

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

13.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

13.5

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

13.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

13.5

455

6275

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

34.1

13.5

JAL30

NOMESCO Finland

Omentectomy

18.3

13.3

KBH20

NOMESCO Finland

Replantation of ureter

21.2

13.3

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

13.2

434

6015

G04BE01

ATC

alprostadil; parenteral, urethral

3.1

13.2

226

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

13.1

197

1069

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

15.1

13.1

SPAT1131

SPAT

Colonoscopy

2.4

13.0

110

470

R03AC02

ATC

salbutamol; inhalant

0.7

12.8

958

11670

G47.3

ICD-10 Finland

Sleep apnoea

0.7

12.8

322

4694

M25.5

ICD-10 Finland

Pain in joint

0.7

12.7

385

5417

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.0

12.6

233

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

15.5

12.6

WGA11

NOMESCO Finland

Planning of pain management

32.1

12.6

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

0.7

12.5

461

6266

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

12.5

L01BC04

ATC

carmofur; oral

+∞

12.5

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

12.5

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

12.5

GDB20

NOMESCO Finland

Segmental resection of lung

+∞

12.5

JAG00

NOMESCO Finland

Repair of other hernia

17.4

12.5

KA3EB

NOMESCO Finland

Antegrade pyelography

10.1

12.5

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

130.4

12.4

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

12.3

260

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.1

12.3

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

12.2

172

917

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

4.6

12.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

12.1

457

3206

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.1

12.1

139

681

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.3

12.1

112

500

JHA10

NOMESCO Finland

Biopsy of anal canal

18.1

12.0

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

9.3

12.0

M01AC06

ATC

meloxicam; systemic, rectal

0.7

12.0

650

8310

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

13.4

11.9

S77

ICPC

Malignant neoplasm of skin

13.4

11.9

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.5

11.9

K65.0

ICD-10 Finland

Acute peritonitis

4.0

11.8

116

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.9

11.8

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.4

11.8

WX610

NOMESCO Finland

Patient controlled analgesia

9.6

11.7

K60.4

ICD-10 Finland

Rectal fistula

16.4

11.6

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

30.1

11.6

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

30.1

11.6

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

65.1

11.6

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

8.6

11.5

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

11.5

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

11.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

11.5

L01EX05

ATC

regorafenib; oral

+∞

11.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

11.5

KFC10

NOMESCO Finland

Bilateral orchiectomy

+∞

11.5

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

11.5

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

11.5

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

11.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

11.5

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

11.5

JFC10

NOMESCO Finland

Ileotransversostomy

+∞

11.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

11.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

11.5

K43.3

ICD-10 Finland

Parastomal hernia with obstruction, without gangrene

120.4

11.4

JFB50

NOMESCO Finland

Other resection of colon

15.1

11.3

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

10.6

11.2

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.8

11.1

118

ZXC40

NOMESCO Finland

Use of ultrasound

7.6

11.1

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

11.1

103

461

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

11.0

102

455

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

5.4

11.0

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

10.9

256

1601

UJF32

SPAT

3.4

10.9

156

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

43.4

10.9

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

11.9

10.8

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.8

10.7

K91.3

ICD-10 Finland

Postoperative intestinal obstruction

28.1

10.7

E34.0

ICD-10 Finland

Carcinoid syndrome

60.2

10.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.8

10.6

244

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.1

10.6

112

532

JGA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in rectum

11.2

10.5

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

14.2

10.5

JFB43

NOMESCO Finland

Left hemicolectomy

7.3

10.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

110.3

10.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

110.3

10.4

JFC20

NOMESCO Finland

Other enterocolostomy

110.3

10.4

Z93.8

ICD-10 Finland

Other artificial opening status

110.3

10.4

L02AE04

ATC

triptorelin; parenteral

110.3

10.4

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

110.3

10.4

JF2CG

NOMESCO Finland

Extensive MRI of colon

110.3

10.4

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

10.4

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

10.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

10.4

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

10.4

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

10.4

8010/3-C20.9

ICD-O-3

Carcinoma, NOS, of rectum, NOS

+∞

10.4

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

10.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

10.4

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

10.4

C21.2

ICD-10 Finland

Malignant neoplasm: Cloacogenic zone

+∞

10.4

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.1

10.4

XQ902

NOMESCO Finland

Other photography

7.7

10.4

JFA42

NOMESCO Finland

Endoscopic injection in colon

7.7

10.4

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.6

10.3

120

2093

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.1

10.3

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

4.2

10.3

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

18.8

10.2

RD211

NOMESCO Finland

2.1

10.2

118

583

L02AE03

ATC

goserelin; implant

8.4

10.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

10.0

103

484

N32.1

ICD-10 Finland

Vesicointestinal fistula

10.0

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

9.9

382

5169

JGA96

NOMESCO Finland

Other proctotomy or local operation on rectum

16.7

9.9

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.2

9.8

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

9.8

217

1335

KDE20

NOMESCO Finland

Removal of foreign body from urethra

7.0

9.8

KA1FN

NOMESCO Finland

Isotope renography

7.0

9.8

JFA70

NOMESCO Finland

Suture of small intestine

10.6

9.8

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

8.7

9.8

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.7

9.8

364

4957

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

6.5

9.7

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

55.1

9.6

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

55.1

9.6

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

55.1

9.6

R01AD09

ATC

mometasone; nasal

0.8

9.6

712

8771

A07DA03

ATC

loperamide; oral

2.1

9.6

112

555

JFK00

NOMESCO Finland

Division of adhesive band in intestinal obstruction

7.8

9.6

R15

ICD-10 Finland

Faecal incontinence

2.4

9.6

335

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

0.5

9.6

1558

JFF13

NOMESCO Finland

Terminal enterostomy

10.0

9.5

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

15.0

9.5

C01DA14

ATC

isosorbide mononitrate; oral

0.7

9.5

344

4710

N05AX08

ATC

risperidone; systemic

0.5

9.4

1603

C80.91

ICD-10 Finland

Malignant tumor without specified localization epidermoid carcinoma

100.3

9.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

100.3

9.4

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

100.3

9.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

100.3

9.4

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.2

9.4

153

WX250

NOMESCO Finland

Intercostal blockade

17.6

9.4

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

17.6

9.4

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

9.4

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

9.4

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

9.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

9.4

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

9.4

L01AX03

ATC

temozolomide; systemic

+∞

9.4

8490/3-C20.9

ICD-O-3

Signet ring cell carcinoma of rectum, NOS

+∞

9.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

9.4

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

9.4

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

+∞

9.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

9.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

9.4

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

9.3

137

744

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

10.7

9.3

R18

ICD-10 Finland

Ascites

3.2

9.3

144

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

3.6

9.2

108

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

528

461

12.69

307.65

5.0

1.8

u/ml

52.9

408.6

0.86

476

420

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1516

3873

5.18

307.65

2.6

2.2

umol/l

7.3

8.2

0.82

1405

3335

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3726

2179

64.39

307.65

9.2

1.4

ug/l

30.8

9.1

1.53

3386

1639

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1114

777

18.16

307.65

5.7

1.8

u/ml

506.8

91.0

0.66

1025

618

(3024561) Albumin [Mass/volume] in Serum or Plasma

3415

16479

4.39

307.65

10.4

3.9

g/l

33.3

35.3

71.43

3322

15006

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1273

3205

4.99

307.65

2.1

2.2

u/l

31.9

52.5

0.75

1163

2699

(4035726)

1108

1107

12.57

307.65

1.4

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1495

5089

3.76

307.65

9.5

6.7

mmol/l

105.3

104.3

15.30

1478

4959

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3699

18920

4.68

307.65

14.1

3.8

umol/l

11.1

12.3

6.20

3634

17664

(3032080) INR in Blood by Coagulation assay

3224

17077

3.50

307.65

8.4

11.1

inr

1.2

1.4

14.02

798

4679

(3033658) Prothrombin time (PT) actual/Normal

2113

9094

3.29

307.65

5.1

3.6

89.2

84.8

13.55

2099

8838

(3002256) Pathology report gross observation

1146

2946

4.75

307.65

1.3

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2228

8387

3.99

307.65

3.4

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1466

2879

6.79

307.65

2.3

2.0

g/l

0.2

7.11

1424

2595

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3434

16445

4.48

307.65

5.7

3.7

—

(3022145) Colonoscopy Study observation

2187

3847

9.33

307.65

1.7

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

2666

10908

4.10

307.65

3.5

2.2

—

(40768804) Tissue Pathology biopsy report

2587

11859

3.45

307.65

2.7

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3299

20500

2.79

252.33

16.6

6.3

e9/l

3.9

4.4

29.41

2909

17521

(3023368) Bacteria identified in Blood by Culture

2177

11013

2.73

251.90

5.3

3.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2178

11468

2.59

226.35

4.1

2.6

u/l

31.2

35.2

1.57

2120

10756

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2265

12248

2.55

221.23

2.6

2.3

u/l

57.2

60.0

1.64

2182

11188

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

734

2116

3.89

220.35

9.0

10.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4085

29443

3.13

217.41

15.7

5.4

u/l

88.6

76.3

30.66

3993

27154

(3003694) ABO and Rh group [Type] in Blood

1812

8907

2.62

214.84

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

995

3928

2.91

176.84

8.3

7.9

g/l

117.5

122.7

14.64

972

3775

(3015377) Calcium [Moles/volume] in Serum or Plasma

2140

12284

2.30

170.85

7.8

2.1

mmol/l

2.3

2.4

0.77

1962

10139

(3014111) Lactate [Moles/volume] in Serum or Plasma

909

3534

2.92

165.27

6.6

6.8

mmol/l

1.2

1.4

6.58

883

3396

(3016502) Oxygen saturation in Arterial blood

1038

4368

2.74

162.18

8.1

7.4

97.1

95.1

21.92

1004

4197

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1432

7078

2.43

159.54

8.8

2.2

mmol/l

2.5

2.4

20.64

1339

6029

(3037121) Protein [Mass/volume] in Urine

479

1290

4.00

156.35

6.1

2.6

g/l

0.2

0.3

3.70

367

455

(3003396) Base excess in Arterial blood by calculation

1090

4810

2.62

154.08

7.9

7.1

mmol/l

0.7

1.3

5.72

947

3709

(3027801) Oxygen [Partial pressure] in Arterial blood

1093

4841

2.61

153.26

7.9

7.1

kpa

14.9

11.5

57.66

1056

4599

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1093

4844

2.61

153.04

7.9

7.1

kpa

5.2

5.0

8.16

1058

4616

(3014007) Fractional oxyhemoglobin in Arterial blood

715

2556

3.10

150.06

8.5

9.1

95.5

93.5

18.94

715

2543

(3013826) Glucose [Moles/volume] in Serum or Plasma

3330

23601

2.23

149.97

6.1

4.5

mmol/l

7.0

6.9

1.48

3228

22062

(3000991) Gas panel - Venous blood

836

3289

2.85

147.48

7.5

8.2

—

(3002582) Erythrocytes [#/volume] in Urine

2017

11868

2.17

145.44

3.7

3.1

e6/l

85.9

97.9

0.15

1581

9051

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1212

5774

2.45

144.58

5.6

2.5

mmol/l

0.8

23.29

1154

5278

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2706

17935

2.11

141.51

7.6

5.5

mmol/l

1.2

30.29

2519

15814

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2903

19803

2.11

139.97

8.6

5.9

mmol/l

1.2

37.67

2506

16580

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

696

2546

3.01

139.77

8.5

9.1

0.6

0.7

5.96

691

2528

(3030467) Casts [#/volume] in Urine by Automated count

1874

10910

2.15

136.91

3.5

3.0

e6/l

0.5

0.22

1433

8155

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

693

2572

2.97

135.38

8.5

9.0

1.3

1.4

2.87

688

2558

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

599

2065

3.16

133.03

8.8

9.4

mmol/l

24.0

24.4

2.66

581

1880

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

457

1339

3.66

131.47

2.5

3.1

u/ml

0.3

2.65

222

791

(36304419) Bacteria [Presence] in Urine

1784

10430

2.10

126.71

3.5

3.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

683

2659

2.82

121.45

1.6

—

(40758558) Short blood count panel - Blood

1541

8650

2.13

120.73

13.1

4.8

—

(3018095) Leukocytes [#/volume] in Urine

2129

13752

1.95

110.47

4.3

3.5

e6/l

157.0

108.8

1.40

1635

9769

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1180

6157

2.20

109.93

3.2

2.8

e6/l

2.4

2.1

0.52

657

3392

(3031040) Bacteria [#/volume] in Urine by Automated count

3349

25372

1.97

105.56

5.0

4.4

e6/l

2462.4

1999.2

0.11

406

(3042936) Bacteria identified in Isolate by Culture

1029

5470

2.11

89.18

2.3

2.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1185

6760

1.99

83.92

3.1

2.6

e6/l

1.0

1.2

1.04

656

3964

(3026782) Osmolality of Urine

1289

7619

1.93

81.98

3.2

2.6

mosm/kgh2o

532.2

555.3

3.93

1153

6346

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

996

5516

2.01

75.83

2.2

2.7

20.0

22.4

6.06

869

4595

(3026008) Bacteria identified in Urine by Culture

1753

11661

1.77

74.92

3.5

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

1341

8290

1.84

72.80

2.9

2.5

e6/l

5.2

4.5

0.78

1186

7150

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1037

5912

1.95

72.22

2.2

2.6

g/l

2.3

2.37

978

5407

(3022948) Iron [Moles/volume] in Serum or Plasma

1091

6413

1.90

68.90

2.3

2.6

umol/l

11.6

12.8

5.46

1031

5854

(3020779) Urea [Moles/volume] in Serum or Plasma

705

3702

2.05

61.13

5.2

7.0

mmol/l

9.4

11.1

7.14

677

3494

(42870588) Differential panel, method unspecified - Blood

1786

12632

1.64

56.93

4.4

5.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3256

26829

1.61

53.48

5.5

4.2

—

(3006504) Eosinophils/100 leukocytes in Blood

2270

17200

1.59

53.36

4.8

5.6

2.7

3.0

6.57

2115

15743

(3019069) Monocytes/100 leukocytes in Blood

2279

17287

1.58

53.30

5.1

5.9

9.1

8.9

1.60

2125

15890

(3022096) Basophils/100 leukocytes in Blood

2217

16742

1.58

52.63

4.7

5.6

0.6

0.7

17.15

2062

15348

(3002030) Lymphocytes/100 leukocytes in Blood

2313

17653

1.58

52.35

4.9

5.8

22.8

26.8

44.62

2136

16124

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1494

10339

1.63

50.61

2.2

2.3

mg/l

3.3

3.0

4.94

1270

8728

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4305

38407

1.87

50.25

29.2

14.0

mg/l

36.7

24.8

87.92

4043

30324

(3025941) Bacteria identified in Stool by Culture

410

1880

2.29

49.77

1.3

—

(3018418) pH of Serum or Plasma

1612

11430

1.61

49.12

5.2

3.3

7.4

0.14

322

2004

(3048689) Calprotectin [Mass/mass] in Stool

693

3891

1.91

48.79

1.6

2.2

ug/g

272.9

155.9

6.64

546

3042

(3018010) Neutrophils/100 leukocytes in Blood

2271

17474

1.55

48.16

4.7

5.6

61.0

58.1

18.74

2111

16058

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1042

6714

1.70

45.85

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

282

1151

2.54

44.28

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

362

1675

2.25

42.86

2.0

1.8

ug/l

2.4

1.7

0.56

324

1438

(3018572) Chloride [Moles/volume] in Blood

236

921

2.64

40.61

8.9

6.9

mmol/l

106.7

104.9

7.86

215

824

(3039000) Anion gap in Blood

236

921

2.64

40.61

8.9

6.8

mmol/l

11.0

11.3

1.09

215

824

(3001604) Monocytes [#/volume] in Blood

2337

18553

1.49

39.98

4.7

5.3

e9/l

0.6

0.32

1947

15803

(3006315) Basophils [#/volume] in Blood

2349

18680

1.49

39.77

4.7

5.3

e9/l

0.0

14.31

1963

15948

(3019198) Lymphocytes [#/volume] in Blood

2381

19038

1.48

38.90

4.8

5.4

e9/l

1.7

1.8

1.45

2036

16511

(3047181) Lactate [Moles/volume] in Blood

295

1307

2.34

38.63

7.9

6.0

mmol/l

1.4

1.3

0.25

261

1160

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1955

15059

1.49

38.35

2.7

2.9

ug/l

158.1

142.8

0.73

1796

13673

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

225

886

2.61

38.01

3.5

1.5

u/ml

38.8

26.5

1.10

218

839

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

675

4070

1.76

37.00

4.8

3.3

—

(3013115) Eosinophils [#/volume] in Blood

2393

19320

1.46

36.19

4.8

5.5

e9/l

0.2

10.30

2042

16703

(3003458) Phosphate [Moles/volume] in Serum or Plasma

791

5060

1.67

34.77

4.6

5.6

mmol/l

1.0

0.91

741

4625

(3008152) Bicarbonate [Moles/volume] in Arterial blood

501

2857

1.84

32.92

8.6

7.0

mmol/l

24.7

24.5

0.55

473

2650

(3021589) Normoblasts [#/volume] in Blood

2068

16487

1.43

32.10

15.8

8.8

e9/l

0.0

0.31

1673

13449

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

360

1858

2.01

31.92

6.8

4.9

1.6

0.33

334

1744

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

449

2497

1.88

31.92

1.7

1.6

—

(40768441) Liver Pathology biopsy report

135

5.02

31.41

1.1

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

353

1835

1.99

30.65

7.0

4.9

0.9

0.72

328

1724

(40768800) Prostate Pathology biopsy report

112

338

3.37

30.49

1.2

1.1

—

(3051651) Icteric interference index of Serum or Plasma

187

4.28

30.44

5.2

4.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4014

36337

1.53

30.28

30.1

13.0

ml/min/173m2

78.1

75.1

17.79

3578

29425

(3019060) Gas panel - Arterial blood

507

2981

1.78

29.99

6.5

4.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.05

29.83

1.3

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

206

888

2.38

28.69

2.1

2.4

g/l

3.7

3.6

0.53

199

839

(3018677) aPTT in Platelet poor plasma by Coagulation assay

921

6385

1.54

28.37

2.0

1.9

30.1

0.09

903

6185

(40768795) Lymph node Pathology biopsy report

5.97

27.26

1.2

1.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

634

4071

1.64

26.97

3.2

2.7

u/l

256.7

239.6

1.08

606

3759

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

135

497

2.76

26.08

1.2

1.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

686

4558

1.59

25.24

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

701

4707

1.57

24.60

1.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

228

1107

2.11

23.82

1.9

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

179

795

2.30

23.32

1.4

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

695

4715

1.55

23.21

1.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

614

4054

1.59

23.08

3.1

3.7

kpa

5.7

5.8

1.80

594

3928

(3002032) Base excess in Venous blood by calculation

609

4037

1.58

22.48

3.2

3.7

mmol/l

1.9

0.12

488

3279

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

401

2411

1.72

21.74

1.5

1.4

—

(3044889) 12 lead EKG panel

3192

28379

1.35

21.22

4.4

4.2

—

(40768793) Breast Pathology biopsy report

175

3.69

20.34

1.4

1.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4357

40921

1.51

20.01

35.0

17.1

mmol/l

139.3

139.8

35.09

4304

39765

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

197

3.48

19.84

1.2

1.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

328

1918

1.76

19.60

2.9

4.1

mmol/l

24.2

0.00

305

1686

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3597

38832

0.74

19.54

4.2

4.9

mmol/l

4.5

0.86

3252

35623

(3023103) Potassium [Moles/volume] in Serum or Plasma

4362

41022

1.50

19.44

35.1

17.3

mmol/l

3.9

4.0

38.78

4307

39808

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

124

511

2.46

19.16

5.8

6.6

mg/l

12.4

12.1

0.26

108

462

(3013707) Erythrocyte sedimentation rate by Westergren method

3246

29126

1.33

19.08

3.4

4.2

mm/h

16.7

12.6

27.88

2976

26668

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3565

38502

0.74

19.04

4.2

4.8

mmol/l

1.4

0.69

3201

35067

(3025468) Yersinia sp identified in Specimen by Organism specific culture

111

437

2.57

18.88

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

112

445

2.55

18.70

1.4

1.3

—

(3049717) Cytology report of Urine Cyto stain

261

1450

1.84

18.50

2.6

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

436

2.56

18.46

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

110

439

2.54

18.21

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

102

393

2.63

18.14

4.8

3.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

110

442

2.52

17.96

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

112

457

2.48

17.71

1.4

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

418

6299

0.63

17.52

1.2

1.3

iu/ml

52.2

38.3

0.61

129

1909

(3002385) Erythrocyte distribution width [Ratio]

3392

30785

1.32

17.43

38.7

16.8

14.6

13.7

112.03

3354

29955

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2668

23456

1.29

17.40

3.6

3.0

u/l

63.8

50.2

7.07

2511

21306

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

172

847

2.07

17.37

2.3

213.5

195.3

1.89

164

806

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.49

17.12

7.2

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3720

39781

0.74

17.08

4.7

5.5

mmol/l

2.6

0.29

3327

36336

(3027945) Reticulocytes/100 erythrocytes in Blood

678

4866

1.45

16.88

2.3

2.1

1.7

0.04

603

4212

(40762365) Oxygen content in Arterial blood by calculation

5.35

16.81

4.5

2.3

ml/dl

13.8

15.3

2.00

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

394

5963

0.63

16.78

1.2

u/ml

12.4

14.4

0.19

142

2190

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

181

927

1.99

16.42

2.2

2.0

85.1

89.6

1.81

175

878

(4281824)

177

3.36

16.37

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3479

37469

0.76

16.02

6.0

6.6

mmol/mol

40.9

0.01

3147

34356

(3013512) EKG study

1529

12608

1.31

15.80

4.2

4.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

198

1062

1.90

15.69

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

198

1069

1.89

15.39

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

196

1055

1.89

15.37

1.2

—

(40761511) CBC panel - Blood by Automated count

4209

39676

1.39

15.18

28.2

13.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

3637

33577

1.31

14.99

31.7

15.5

37.4

39.5

31.57

2451

21551

(3052851) Hemolysis interference index of Serum or Plasma

206

1140

1.84

14.83

5.0

3.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3471

37271

0.77

14.58

3.8

4.3

mmol/l

1.3

0.02

3088

33632

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

465

3198

1.50

14.27

4.7

3.1

mmol/l

1.2

0.92

414

2708

(3024354) Oxygen [Partial pressure] in Venous blood

486

3385

1.48

14.01

2.9

3.1

kpa

4.6

4.5

0.42

467

3266

(3012501) Base excess in Blood by calculation

167

892

1.90

13.45

4.5

4.3

mmol/l

2.7

2.6

0.15

120

590

(3018405) Lactate [Moles/volume] in Arterial blood

264

1619

1.67

13.28

4.6

4.1

mmol/l

1.3

1.4

0.66

255

1586

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

271

1677

1.65

13.17

2.0

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4323

41139

1.38

12.92

18.8

9.5

u/l

24.2

25.8

9.87

4241

39246

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

350

2318

1.55

12.80

2.4

2.5

—

(3019225) pH of Specimen

562

4101

1.42

12.61

4.4

3.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

153

818

1.90

12.32

2.4

2.7

umol/l

34.2

34.8

0.09

126

690

(3021601) Nitrite [Presence] in Urine by Test strip

2163

19045

1.24

12.02

5.6

4.9

estimate

0.0

0.80

471

3269

(3010421) pH of Blood

184

1053

1.78

11.92

4.3

4.2

7.4

0.65

166

868

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

177

2.96

11.80

2.5

1.5

—

(40761536) Microorganisms panel - Urine sediment

426

2990

1.46

11.78

4.9

4.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

248

1551

1.63

11.58

1.9

1.7

—

(3036489) Thrombin time

208

1244

1.70

11.54

2.0

1.9

21.4

21.3

0.05

197

1093

(3009261) Glucose [Presence] in Urine by Test strip

2176

19271

1.23

11.15

4.2

3.7

estimate

0.0

1.60

466

3119

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

416

2940

1.45

11.09

1.3

1.5

—

(1616796) Gas panel - Central venous blood

160

903

1.80

10.89

3.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

100

489

2.07

10.44

2.9

3.2

1.4

2.46

365

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

889

10906

0.77

10.43

1.6

mmol/l

1.4

1.3

1.20

734

9010

(3023520) Reticulocytes [#/volume] in Blood

496

3662

1.39

10.35

2.3

2.2

e9/l

66.4

68.0

0.51

368

2808

(3037522) Nuclear Ab [Titer] in Serum

341

4834

0.68

10.26

1.3

titre

582.4

515.7

0.20

1051

(3017143) Hepatitis C virus Ab [Presence] in Serum

392

2781

1.44

10.24

1.3

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

2139

19035

1.22

10.10

4.2

3.7

estimate

0.0

0.50

460

3210

(3004716) Salmonella sp identified in Stool by Organism specific culture

226

1439

1.60

9.85

1.2

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

157

2.88

9.83

1.9

2.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2643

28766

0.83

9.73

3.3

3.7

pmol/l

15.1

15.0

0.83

2329

25690

(3020891) Body temperature

273

1822

1.53

9.68

5.3

5.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

234

1531

1.55

9.09

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

15.60

9.02

1.1

—

(3045142) Bone marrow Pathology biopsy report

291

2.28

8.98

1.3

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

167

1012

1.67

8.90

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

289

1988

1.48

8.88

1.6

1.5

g/l

1.7

1.5

2.55

251

1693

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

437

3241

1.38

8.87

4.3

2.4

ml/min/173m2

61.9

62.7

0.16

178

1256

(3003434) Protein [Mass/volume] in Pleural fluid

486

1.97

8.83

1.4

1.5

g/l

31.0

28.6

0.97

424

(3043410) Blood group antigens tested for on Red Blood Cells

3.31

8.60

2.5

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

144

848

1.72

8.54

1.7

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

172

2.63

8.33

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

172

2.63

8.33

1.3

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

411

3053

1.38

8.26

3.2

3.7

1.1

0.8

1.58

158

666

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1014

8509

1.24

8.14

3.5

4.1

ng/l

808.7

503.5

0.73

846

7179

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

360

2630

1.40

8.00

3.1

3.5

mmol/l

2.1

1.8

0.55

254

1918

(3007164) IgA [Mass/volume] in Serum or Plasma

759

6174

1.27

7.98

1.4

1.3

g/l

2.6

2.7

0.59

419

3502

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

877

7256

1.25

7.98

1.2

u/ml

1.3

2.1

1.46

228

1899

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

144

867

1.68

7.91

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

144

867

1.68

7.91

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

394

2936

1.37

7.77

3.3

3.8

0.2

0.1

1.45

146

618

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

240

2.31

7.72

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

234

2.32

7.70

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

136

813

1.69

7.68

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3697

38708

0.83

7.67

4.5

5.1

mmol/l

6.1

0.87

3303

34866

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

401

1.99

7.56

1.5

1.4

pmol/l

222.0

82.3

0.88

388

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

372

2767

1.37

7.43

3.1

3.6

kpa

5.1

5.2

1.29

344

2524

(3012441) Differential panel - Pleural fluid

364

2.02

7.35

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

781

6436

1.25

7.32

21.0

29.9

inr

1.3

1.5

3.38

109

853

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

7.29

1.0

0.0

—

(3009343) pH of Capillary blood

366

2725

1.37

7.27

3.1

3.6

7.4

0.30

329

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1579

13968

1.19

7.25

2.6

3.2

ng/l

1399.5

1575.1

1.14

1393

12059

(3024731) MCV [Entitic volume]

4390

42463

1.28

7.22

44.5

20.5

91.4

91.6

2.01

4345

41619

(3000963) Hemoglobin [Mass/volume] in Blood

4391

42475

1.28

7.21

45.0

20.7

g/l

126.8

136.4

279.41

4346

41638

(3035941) MCH [Entitic mass]

4390

42466

1.28

7.19

44.5

20.5

30.2

30.5

24.55

4344

41624

(3026361) Erythrocytes [#/volume] in Blood

4390

42469

1.28

7.17

44.6

20.6

e12/l

4.3

4.5

158.18

4289

40906

(3021879) Hepatitis B virus core Ab [Presence] in Serum

244

1698

1.46

7.12

1.2

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

149

931

1.62

7.12

3.2

2.8

kpa

7.9

7.8

0.34

143

850

(3010813) Leukocytes [#/volume] in Blood

4390

42475

1.28

7.11

44.7

20.6

e9/l

6.7

6.8

1.21

4289

40911

(40767503) Oxygen content in Capillary blood by calculation

142

877

1.64

7.11

3.0

2.5

15.4

16.3

1.27

469

(3007461) Platelets [#/volume] in Blood

4388

42455

1.27

7.10

44.7

20.6

e9/l

247.7

240.7

8.75

4296

41067

(40768806) Pleura Pathology biopsy report

336

2.04

7.04

1.4

1.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

130

787

1.67

7.04

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.15

6.97

1.3

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

100

567

1.78

6.85

1.5

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

204

1387

1.49

6.71

5.0

4.5

mmol/l

3.8

3.9

3.36

189

1306

(3004119) Hemoglobin [Mass/volume] in Venous blood

367

2784

1.34

6.48

2.8

3.3

g/l

123.4

130.4

6.98

357

2706

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

519

1.79

6.44

2.5

5.5

iu/ml

948.0

873.7

—

(3021901) Oxygen saturation in Capillary blood

129

801

1.63

6.36

3.2

2.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

456

1.83

6.34

1.2

1.1

g/l

1.6

1.5

1.14

401

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

155

2.46

6.25

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

155

2.46

6.25

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

432

1.84

6.13

1.4

1.5

e6/l

868.4

2675.0

2.15

323

(3002179) Metamyelocytes/100 leukocytes in Blood

365

2793

1.33

6.09

3.1

3.6

0.7

0.6

0.86

114

495

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

280

2057

1.38

6.08

2.3

2.7

0.7

0.05

270

1963

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

146

2.48

6.01

1.6

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

146

2.48

6.01

1.6

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

146

2.48

6.01

1.6

1.3

—

(3024928) Oxygen saturation in Venous blood

140

900

1.57

6.00

1.8

3.2

—

(3025159) Blasts/100 leukocytes in Blood

365

2799

1.33

6.00

3.3

3.8

0.5

0.4

0.07

123

542

(3028308) Erythrocytes [#/volume] in Pleural fluid

387

1.87

5.91

1.4

1.5

e6/l

21958.9

64236.3

1.15

232

(3020682) Albumin/Creatinine [Ratio] in Urine

1334

14981

0.85

5.89

4.2

4.0

mg/mmol

12.6

8.5

1.06

876

9554

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

106

643

1.66

5.77

4.1

3.5

59.2

58.7

0.13

106

643

(1002224) Polysomnography panel

1240

0.56

5.65

1.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

110

2.65

5.55

1.4

1.5

1.0

2.3

1.33

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

146

2.41

5.53

1.6

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

159

1073

1.50

5.50

1.3

1.4

ug/g

257.6

284.3

0.95

652

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

105

2.68

5.48

1.6

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

523

1.71

5.47

1.9

1.8

89.2

89.5

0.13

516

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

320

1.92

5.42

1.3

u/l

1364.0

274.3

0.50

302

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

106

2.65

5.39

1.6

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

106

2.65

5.39

1.6

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

300

2276

1.34

5.34

3.3

3.2

mmol/l

24.7

25.2

1.52

287

2198

(46235355) HIV 1 and 2 tests - Meaningful Use set

442

3539

1.27

5.27

1.3

1.5

—

(3012516) Albumin [Mass/volume] in Urine

1266

14176

0.86

5.26

3.4

3.2

mg/l

336.9

280.8

0.20

868

9097

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

214

2.11

5.25

1.7

1.9

u/field

2.7

1.7

0.48

139

(3024891) Influenza virus A+B Ag [Presence] in Specimen

129

850

1.53

5.02

1.1

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1223

13676

0.86

4.93

2.1

2.2

u/l

217.8

230.2

0.17

1152

12730

(4034850)

1473

0.62

4.89

12.9

10.3

—

(3045788) Cell count panel - Pleural fluid

333

1.84

4.84

1.5

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1843

16898

1.14

4.83

3.7

4.0

ng/l

64.2

76.3

0.16

1466

12563

(3009508) Creatinine [Moles/volume] in Urine

1296

14413

0.86

4.83

3.3

3.2

mmol/l

7.5

0.00

1044

11989

(3033799) Differential panel - Peritoneal fluid

2.64

4.81

2.6

1.9

—

(4094501)

1198

0.60

4.66

1.0

1.1

—

(4010399)

233

3082

0.74

4.64

1.3

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

368

1.78

4.61

2.7

2.9

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.68

4.57

1.3

1.9

g/l

11.0

13.9

1.11

(1761868) Lipid panel - Serum or Plasma

1077

12089

0.86

4.50

2.9

3.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

372

1.76

4.45

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

572

0.43

4.42

3.6

4.5

umol/l

313.1

352.1

0.60

481

(3041096) Erythrocytes [Presence] in Urine by Automated

1091

9698

1.16

4.36

4.7

3.4

—

(3045414) Leukocytes [Presence] in Urine

239

1817

1.33

4.25

2.2

1.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1063

9455

1.16

4.20

3.3

3.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

117

788

1.50

4.18

1.3

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

235

1.92

4.14

1.3

u/l

14.6

11.5

0.22

208

(3008898) HLA-B27 [Presence]

897

0.56

4.11

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3413

35459

0.88

4.11

4.0

4.5

mu/l

2.0

2.1

0.23

3014

31872

(3015235) Bicarbonate [Moles/volume] in Capillary blood

158

1131

1.41

4.11

3.3

3.1

mmol/l

24.1

24.8

1.05

140

990

(3022313) Gas panel - Capillary blood

258

1994

1.31

4.10

2.9

3.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

995

11164

0.86

4.08

2.6

umol/l

4177.9

5626.1

0.54

842

9467

(3021960) Folate [Moles/volume] in Serum or Plasma

1155

10379

1.15

3.93

1.6

nmol/l

20.1

20.3

0.12

986

8742

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

291

1.79

3.89

1.6

1.4

—

(21494755) Public health laboratory ask at order entry panel

149

2050

0.72

3.87

1.2

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

138

977

1.42

3.84

2.8

2.1

g/l

123.0

130.8

2.96

103

721

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1391

0.66

3.83

1.2

u/ml

6.0

0.7

—

140

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

107

2.34

3.82

6.3

1.1

u/ml

65.0

64.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1257

0.65

3.80

1.2

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

164

2212

0.73

3.77

1.2

1.3

au/ml

104.9

55.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

108

2.32

3.75

1.8

2.6

e6/l

738.7

623.2

0.14

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1407

0.67

3.73

1.2

1.6

—

(3044007) Cell count panel - Peritoneal fluid

2.51

3.70

2.1

2.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

859

7589

1.16

3.69

4.2

—

(3011648) Oxygen content in Venous blood

311

1.74

3.68

1.2

2.1

11.2

11.1

0.07

311

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

313

3857

0.80

3.63

1.5

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

116

2.25

3.63

3.3

2.6

—

(3029937) Albumin [Presence] in Urine by Test strip

1166

10542

1.14

3.59

4.5

4.1

estimate

0.0

0.28

417

3151

(3000494) Fungus identified in Specimen by Culture

522

4440

1.20

3.56

1.6

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

323

1.71

3.52

2.5

2.8

60.5

60.0

0.06

207

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

220

1703

1.30

3.50

2.9

3.9

mmol/l

24.7

24.8

0.28

196

1546

(3032773) Endomysium IgG Ab [Titer] in Serum

272

1.77

3.48

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

287

1.75

3.47

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

287

1.75

3.47

1.4

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

287

1.75

3.47

1.4

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

200

1.91

3.47

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

201

1.90

3.42

1.6

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

133

2.11

3.38

1.4

54.4

64.8

0.58

106

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.92

3.29

1.7

2.4

—

(3002619) Bacteria identified in Specimen by Culture

2.58

3.20

1.3

—

(3019977) pH of Arterial blood

250

1.77

3.19

2.9

2.1

7.4

0.27

(3017732) Neutrophils [#/volume] in Blood

308

2519

1.24

3.15

4.7

3.0

e9/l

4.2

0.09

249

1792

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1056

0.66

3.08

1.3

1.6

mg/l

2.7

4.1

0.90

753

(3045424) Erythrocytes [Presence] in Urine

666

1.45

3.05

1.7

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

191

2439

0.77

3.03

2.3

2.4

au/ml

48.3

25.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

338

1.63

3.02

3.3

3.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

157

1187

1.33

3.01

5.1

4.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

285

1.69

3.00

1.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

160

2088

0.76

3.00

1.2

1.3

u/ml

222.6

237.8

0.09

139

1926

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

497

1.52

3.00

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

733

0.60

2.99

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

496

5736

0.85

2.99

11.2

7.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

915

8246

1.13

2.93

1.7

mg/l

2.1

1.3

4.73

749

6372

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

220

1.78

2.92

2.8

1.4

u/l

155.5

1893.7

0.89

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

2.83

2.91

2.5

1.1

ug/l

0.7

3.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1173

0.69

2.91

1.2

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1289

0.70

2.90

1.2

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

130

1737

0.74

2.89

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

351

1.60

2.86

1.7

2.1

u/field

2.8

1.7

0.74

124

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

107

1469

0.72

2.84

1.4

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

569

1.47

2.83

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

238

1.73

2.80

1.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

637

1.44

2.79

1.3

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.23

2.77

1.1

1.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.34

2.75

1.0

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

348

4116

0.83

2.74

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

2.20

2.73

2.0

2.4

e6/l

22819.3

25587.5

0.03

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.20

2.73

1.3

1.2

ug/l

740.4

91.4

0.48

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

412

1.54

2.71

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1155

0.70

2.70

1.5

e6/l

18231.2

14174.9

0.17

838

(3035880) pH of Pleural fluid

197

1.78

2.67

1.2

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

350

1.58

2.66

1.3

1.2

u/l

83.4

57.8

0.39

226

(3035320) C reactive protein [Mass/volume] in Body fluid

257

1.68

2.66

2.4

2.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

213

1.74

2.62

1.6

1.5

u/l

9.5

5.4

0.54

(3014051) Protein [Presence] in Urine by Test strip

126

947

1.34

2.56

2.4

2.2

—

(36660697) Celiac disease serology panel - Serum

315

2643

1.20

2.56

1.1

1.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

7.15

2.55

1.2

1.9

umol/l

87.6

180.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

5.46

2.54

1.3

2.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.42

2.53

2.1

1.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.50

2.52

1.6

1.4

26.0

7.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

501

1.46

2.52

7.0

21.4

mmol/l

6.7

7.5

2.53

410

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

808

0.65

2.51

1.2

1.4

e6/l

331.9

1068.2

1.24

674

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

807

0.65

2.50

1.1

1.3

e6/l

5.3

25.0

1.55

636

(3007566) Smooth muscle Ab [Titer] in Serum

121

909

1.34

2.48

1.1

1.2

titre

50.0

106.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

496

1.46

2.45

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

531

1.44

2.40

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1082

0.71

2.40

1.5

1.8

nmol/l

41.3

43.4

0.48

1031

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.34

2.39

1.0

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

905

0.68

2.39

1.2

u/ml

2.8

5.2

0.92

149

(3019150) Specific gravity of Urine by Refractometry

807

8879

0.89

2.36

4.2

kg/l

1.0

0.05

135

1320

(44816559) Phosphatidylethanol [Mass/volume] in Blood

620

0.63

2.27

1.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

895

0.69

2.27

1.2

u/ml

9.2

6.8

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.11

2.22

1.1

g/l

20.9

14.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.56

2.21

1.0

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

795

0.68

2.20

1.2

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

118

904

1.31

2.16

2.5

2.6

mg/l

1.8

1.7

0.21

108

793

(3042111) Morphology [Interpretation] in Bone marrow Narrative

527

1.41

2.15

1.8

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1161

0.74

2.13

1.4

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.56

2.09

4.5

1.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.00

2.07

1.4

1.5

mg/l

0.2

6.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.50

2.05

1.1

1.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

579

0.64

2.04

1.3

1.5

59.1

62.3

0.16

383

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

327

0.52

2.02

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

792

0.69

2.02

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

162

0.37

2.00

1.2

1.8

ug/l

19.8

230.1

—

153

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1080

0.74

2.00

1.5

1.6

iu/ml

0.8

3.0

0.41

247

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.34

1.96

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

148

1835

0.80

1.94

1.2

iu/ml

161.2

128.8

0.38

669

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.94

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.97

1.93

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

497

0.62

1.92

1.3

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

189

0.42

1.91

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

235

1.58

1.89

2.1

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

457

0.61

1.88

1.3

e6/l

88065.2

206377.3

0.81

316

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1913

18246

1.08

1.84

2.1

pmol/l

87.2

93.6

7.71

1120

9498

(40765096) Chromosome analysis panel by Banding

2.21

1.84

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

122

1.81

1.83

1.6

2.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

983

0.74

1.83

1.6

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

404

0.59

1.83

1.3

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

318

1.48

1.82

1.8

1.4

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.57

1.80

1.7

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

386

1.43

1.78

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

1.76

1.77

3.7

2.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

131

1.76

1.77

3.7

2.3

—

(3024263) Appearance of Synovial fluid

258

0.50

1.74

1.3

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

515

1.36

1.74

1.3

—

(3000330) Specific gravity of Urine by Test strip

263

2264

1.17

1.69

5.5

3.4

—

(3044290) Cell count panel - Cerebral spinal fluid

717

0.71

1.69

1.1

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

807

1.28

1.66

1.5

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

368

1.42

1.63

1.0

1.1

u/ml

3.2

3.6

0.11

139

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

237

0.51

1.60

1.4

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.50

1.59

20.0

11.8

—

(3017569) Oxygen content in Arterial blood

246

1.51

1.59

2.2

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

375

0.61

1.58

1.1

—

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

255

1.49

1.57

1.9

2.1

ug/min

58.9

216.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

144

1.67

1.57

1.4

2.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

152

1.65

1.56

1.4

2.1

14.5

16.8

0.27

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

433

0.64

1.54

1.3

1.5

35.3

27.9

0.41

286

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.03

1.53

1.0

1.3

ng/l

68.9

156.1

—

(3036603) Volume of Urine

224

1.52

1.53

1.8

1.4

1795.3

1882.0

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

1.52

0.0

1.1

—

79.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.33

1.52

1.0

1.1

nmol/l

189.2

236.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

100

1254

0.79

1.52

2.8

2.2

ug/min

181.3

120.4

0.43

732

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

466

4210

1.12

1.49

2.4

3.1

ng/l

235.2

229.0

0.11

420

3873

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

108

866

1.25

1.48

1.0

1.1

u/ml

1.4

10.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

188

1595

1.19

1.47

2.1

2.3

ug/l

524.4

639.7

0.27

182

1501

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

100

796

1.26

1.46

1.2

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

541

1.32

1.45

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

320

1.41

1.3

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

157

1.59

1.40

1.4

2.0

71.2

71.8

0.06

146

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

346

1.39

1.40

1.8

1.4

—

(3022621) pH of Urine by Test strip

307

2717

1.14

1.40

3.1

3.0

—

(4015189)

139

0.43

1.39

1.5

2.7

—

(3014891) Appearance of Pleural fluid

2.08

1.38

2.3

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

485

1.32

1.37

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.61

1.36

1.0

—

(3037756) Immunofixation for Serum or Plasma

103

831

1.24

1.36

1.6

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

1.34

0.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

151

1.59

1.34

1.3

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

175

1.55

1.34

1.1

5.7

mg/l

48.5

69.4

1.52

115

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

493

5388

0.91

1.32

4.3

5.0

32.8

32.9

0.10

314

3563

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

357

0.64

1.32

1.1

—

25.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

150

0.47

1.30

1.1

u/ml

—

10.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.50

1.30

1.0

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.09

1.27

1.3

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

472

0.70

1.27

1.1

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.74

1.24

1.3

1.4

—

(3000492) Spirometry study

300

3356

0.89

1.24

1.4

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

119

0.42

1.24

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

119

0.42

1.24

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

119

0.42

1.24

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

119

0.42

1.24

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

265

0.60

1.22

1.9

1.8

—

(3047189) Immunofixation for 24 hour Urine

155

1.55

1.22

1.5

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

330

1.37

1.22

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.63

1.21

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

156

1.54

1.19

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

851

0.78

1.19

1.4

1.6

—

(3045716) Anion gap in Serum or Plasma

230

1.44

1.19

3.2

2.3

mmol/l

8.6

9.4

0.69

172

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.75

1.18

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

1.16

0.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.05

1.15

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

335

3025

1.11

1.14

1.9

1.8

nmol/l

412.0

366.9

3.99

311

2712

(3025018) Bordetella pertussis Ab [Titer] in Serum

153

0.52

1.13

1.1

1.2

—

(3003338) MCHC [Mass/volume]

3227

31619

1.06

1.13

39.7

18.5

g/l

329.8

332.5

50.52

3202

31327

(3006922) Hepatitis E virus Ab [Presence] in Serum

191

1.47

1.13

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

492

1.28

1.13

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

151

1.53

1.11

1.7

2.3

91.1

93.1

0.10

141

(3006245) CD3-CD19+ cells/100 cells in Blood

1.78

1.10

1.3

2.0

17.9

8.4

0.73

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

423

0.71

1.10

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

305

0.65

1.10

1.1

—

(3042631) Mycobacterium sp identified in Specimen

539

1.26

1.09

1.8

3.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.38

1.09

3.2

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

280

0.64

1.08

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

202

2293

0.88

1.08

1.8

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

676

1.23

1.06

2.9

3.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

180

0.55

1.06

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.76

1.06

1.3

1.9

35.5

27.6

0.74

(3020630) Protein [Mass/volume] in Serum or Plasma

383

3500

1.10

1.05

2.6

1.6

g/l

64.7

66.7

5.01

346

3095

(3025130) Human papilloma virus identified in Specimen

211

1.42

1.05

1.5

1.8

—

(3026250) Tacrolimus [Mass/volume] in Blood

122

0.49

1.05

41.2

32.8

ug/l

6.2

7.4

—

112

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

159

1377

1.16

1.05

2.7

1.6

mg/l

34.6

40.3

0.55

132

1102

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

134

1562

0.85

1.04

1.6

1.8

u/l

39.2

38.4

0.15

118

1313

(40758292) HTLV I+II Ab panel - Serum

2.27

1.03

1.4

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.63

1.03

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.92

1.02

1.0

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

205

1.42

1.00

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

180

1.45

1.00

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

180

1.45

1.00

1.0

—

(3000012) Reticulocyte production index

239

1.38

1.00

1.4

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

574

1.24

0.99

3.3

2.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1928

18687

1.05

0.98

4.7

4.0

ug/l

2.7

2.3

0.74

1671

16742

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

257

1.36

0.98

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.17

0.98

2.4

2.2

—

(3028707) Methadone [Presence] in Urine by Screen method

212

0.61

0.98

1.3

2.1

—

(44790047)

388

1.29

0.97

1.2

1.4

—

(44806118)

388

1.29

0.97

1.2

1.4

—

(44790049)

388

1.29

0.97

1.2

1.4

—

(44790048)

388

1.29

0.97

1.2

1.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

161

0.56

0.97

1.8

1.3

—

(3021788) Differential panel - Synovial fluid

826

0.81

0.97

1.4

1.5

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

0.00

0.96

0.0

1.5

—

0.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

341

0.70

0.95

1.1

1.4

—

25.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

125

1451

0.86

0.95

1.5

1.6

titre

228.0

297.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

158

1381

1.15

0.94

2.7

1.6

mg/l

53.8

48.8

0.43

132

1112

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

153

1335

1.15

0.94

2.8

1.5

ratio

1.4

2.4

—

118

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

952

0.83

0.92

1.6

1.9

mg/l

10.7

11.7

0.58

872

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

535

1.24

0.92

1.6

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.67

0.91

1.0

1.2

—

(4146454)

545

1.23

0.90

3.2

2.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

741

0.81

0.90

1.7

1.8

iu/l

7.3

4.6

0.46

230

(3014271) Vancomycin [Susceptibility]

262

1.34

0.89

2.9

3.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

332

1.30

0.89

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

245

1.35

0.88

1.3

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

130

0.54

0.87

1.1

miu/ml

722.9

1674.1

—

130

(3052592) Norovirus Ag [Presence] in Stool

1.61

0.87

1.6

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

748

0.81

0.86

1.2

u/ml

6.8

5.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

161

1.43

0.86

1.1

1.3

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.94

0.84

1.0

1.1

—

9.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

284

2593

1.10

0.84

2.0

2.2

nmol/l

11.0

14.7

9.71

235

2244

(4062490)

378

0.74

0.84

1.3

1.4

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.59

0.84

1.3

1.4

15.6

28.2

—

(3016018) Differential panel - Cerebral spinal fluid

355

0.73

0.84

1.2

1.3

—

(3044941) Cell count panel - Synovial fluid

734

0.82

0.84

1.4

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

205

1.37

0.83

1.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1621

15705

1.05

0.82

2.2

nmol/l

75.9

78.6

3.05

1415

13665

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

231

1.34

0.82

2.3

2.4

—

(3003181) Sodium [Moles/volume] in Urine

735

1.19

0.82

1.4

1.3

mmol/l

62.8

63.5

0.05

591

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

121

1.49

0.82

1.3

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

146

1.44

0.82

1.1

—

(4212803)

1.88

0.81

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

118

1024

1.16

0.81

2.3

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1520

14713

1.05

0.80

4.7

4.0

—

(3011288) Drugs identified in Urine by Screen method

283

0.71

0.80

1.0

2.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1458

15062

0.95

0.80

4.1

3.9

20.6

24.2

16.84

721

7505

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

198

1.37

0.79

2.3

2.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.79

0.0

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.82

0.79

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

0.79

0.0

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.79

0.0

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

339

0.74

0.78

1.2

1.7

—

(3016879) Cocaine [Presence] in Urine

418

0.76

0.78

1.1

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

258

0.70

0.78

1.1

u/ml

4.9

2.5

—

107

(3009871) Measles virus Ab [Titer] in Serum

0.52

0.78

1.8

1.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

395

0.76

0.78

1.1

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

182

1.38

0.77

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.77

0.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.77

0.0

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.77

0.0

2.0

—

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

(3004775) Volume in Urine collected for unspecified duration

405

0.76

2.0

2.3

673.6

625.6

0.45

270

(3001019) Free T4 and TSH panel - Serum or Plasma

1080

0.86

0.75

1.5

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

279

0.72

0.75

1.1

1.2

mmol/l

2.6

2.2

0.81

263

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.70

0.75

2.3

2.8

u/field

0.9

0.4

—

(3006653) Thiamine [Moles/volume] in Blood

185

0.65

0.75

1.0

1.2

nmol/l

131.2

139.9

0.27

185

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.64

0.75

1.5

2.3

—

(4133840)

1.54

0.75

1.4

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

570

0.81

0.74

1.3

1.6

g/l

1.0

0.9

0.20

432

(3028717) Thiamine [Mass/volume] in Blood

1.84

0.73

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

242

0.70

0.72

1.1

u/ml

3.3

3.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

106

0.57

0.72

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

109

0.55

0.72

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

322

0.74

0.72

1.3

1.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

142

1.41

0.72

2.0

1.3

umol/l

33.5

9.4

0.54

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

159

0.63

0.72

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1979

19309

1.04

0.72

2.2

2.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

378

0.77

0.71

1.3

1.4

g/l

0.3

0.4

0.93

271

(3028192) IgG subclass 2 [Mass/volume] in Serum

378

0.77

0.71

1.3

1.4

g/l

2.4

3.0

1.31

268

(3027135) IgG subclass 1 [Mass/volume] in Serum

378

0.77

0.71

1.3

1.4

g/l

5.9

6.9

0.76

269

(3022689) Creatine [Moles/volume] in Urine

146

0.62

0.69

1.2

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

391

1.23

0.69

2.3

1.3

—

(3011412) CD3 cells [#/volume] in Blood

204

1.32

0.68

1.4

1.9

e9/l

1.2

1.0

0.41

120

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.85

0.68

1.8

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.85

0.68

1.8

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.85

0.68

1.8

1.0

—

(3034426) Prothrombin time (PT)

119

0.59

0.67

1.1

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

407

0.78

0.66

1.1

—

(3024471) HLA-A [Type]

0.53

0.66

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

0.53

0.66

1.6

3.0

—

(3038026) Centromere Ab [Units/volume] in Serum

328

0.76

0.66

1.1

1.2

—

68.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

339

0.77

0.65

1.1

u/ml

2.1

1.1

0.42

139

(3013166) Neutrophils/100 leukocytes in Synovial fluid

155

0.64

0.65

1.1

1.3

48.3

57.4

—

132

(3005719) IgG [Mass/volume] in Serum or Plasma

262

2419

1.09

0.65

2.8

2.2

g/l

9.8

10.9

4.18

241

2204

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

515

0.81

0.64

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

848

0.86

0.63

1.3

1.5

nmol/l

1.1

0.8

1.07

695

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

104

1.44

0.62

2.4

2.3

mmol/l

8.0

7.8

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

347

0.78

0.62

1.1

u/ml

8.5

3.7

0.55

161

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

0.58

0.61

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

346

0.78

0.61

2.2

2.0

ug/l

2.3

2.0

0.31

286

(3020650) Glucose [Presence] in Urine

1.48

0.60

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

715

0.85

0.59

1.2

u/l

127.7

28.8

0.90

615

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

411

0.80

0.59

1.1

u/ml

5.6

1.4

0.43

165

(21494814) CD8 cells/100 lymphocytes in Specimen

1.50

0.59

1.5

2.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

585

0.84

0.59

1.1

iu/ml

172.8

686.1

0.59

118

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.51

0.58

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

112

0.62

0.58

1.1

1.5

ug/l

10.0

9.2

—

112

(3028433) Virus identified in Specimen by Culture

114

0.61

0.58

1.4

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

275

0.76

0.56

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

531

1.17

0.56

1.5

2.2

mg/l

59.0

24.7

1.07

126

(3027008) Opiates [Presence] in Urine

439

0.82

0.55

1.1

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

1.34

0.54

1.4

1.8

umol/l

95.6

145.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

239

0.75

0.54

1.0

1.1

nmol/l

0.1

9.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

205

0.73

0.54

1.1

—

(3048879) Bone marrow aspiration report

1.41

0.54

1.1

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.43

0.52

1.1

1.3

—

(40761535) Cells panel - Urine sediment

348

3680

0.94

0.51

3.2

3.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

135

1.33

0.51

1.1

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

206

1.26

0.50

1.5

1.3

u/l

49.4

30.9

1.17

140

(3051593) INR in Capillary blood by Coagulation assay

243

1.24

0.49

10.6

10.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.43

0.49

1.3

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.52

0.48

1.7

1.6

—

(3028300) Cannabinoids [Presence] in Urine

442

0.84

0.48

1.1

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

244

1.23

0.48

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.46

0.46

1.0

—

(3016228) CD19 cells/100 cells in Blood

1.41

0.46

1.5

2.2

6.8

7.9

0.21

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1055

0.90

0.46

1.3

1.4

g/l

0.3

0.2

0.94

1002

(3021387) Prolactin [Units/volume] in Serum or Plasma

590

0.86

0.46

1.5

1.8

mu/l

235.0

289.8

1.39

545

(21494434) Karyotype in Bone marrow

319

1.19

0.45

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.43

0.45

1.0

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

468

1.16

0.45

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

297

0.81

0.44

1.1

u/ml

6.0

2.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

356

3742

0.95

0.44

1.5

1.8

1.6

0.25

299

3171

(3050129) First trimester maternal screen panel - Serum or Plasma

1.40

0.44

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

148

1365

1.09

0.43

2.0

2.9

—

(3000764) Benzodiazepines [Presence] in Urine

437

0.85

0.43

1.1

1.8

—

(3023419) Bacteria identified in Sputum by Culture

565

0.87

0.43

2.0

2.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

131

0.69

0.43

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.65

0.42

1.3

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

122

1.31

0.42

1.1

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

660

1.12

0.42

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.63

0.42

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.38

0.41

1.6

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.52

0.41

1.6

1.3

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.9

—

1.6

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.1

—

(3013762) Body weight Measured

0.00

0.41

0.0

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.36

0.41

1.4

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.39

0.40

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1.39

0.40

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

433

0.85

0.40

1.1

1.7

—

(3006462) Nitrate [Presence] in Urine

186

1.24

0.40

4.1

3.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

101

0.69

0.39

1.0

1.1

—

(4027681)

171

0.76

0.39

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.43

0.39

1.2

u/l

8.8

9.8

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.39

0.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1.38

0.38

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1.38

0.38

1.3

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

301

0.83

0.37

1.1

—

3.9

—

(3005033) Fetal Nuchal fold Thickness US

1.30

0.37

1.3

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

114

0.70

0.37

1.0

1.1

—

39.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.29

0.36

1.3

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

385

0.86

0.36

1.8

1.7

u/ml

40.1

25.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.63

0.35

1.4

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

244

0.82

0.34

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

156

0.77

0.34

1.1

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

566

1.11

0.34

1.4

1.3

iu/l

38.2

32.4

0.66

492

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

243

0.82

0.33

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

243

0.82

0.33

1.2

1.1

—

(3003129) Base excess in Capillary blood by calculation

133

0.75

0.33

1.0

1.7

mmol/l

-0.8

0.5

—

126

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.30

0.33

1.7

4.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.68

0.33

1.0

1.2

—

(4211845)

210

1.19

0.32

4.0

3.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.28

0.32

1.3

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.35

0.32

1.4

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

132

0.76

0.32

1.1

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

623

0.90

0.32

1.3

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

241

0.83

0.31

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

241

0.83

0.31

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

174

1.21

0.31

1.5

1.4

nmol/l

0.4

0.2

0.37

138

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.35

0.31

1.3

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

100

1079

0.93

0.31

1.4

g/l

1.1

1.2

0.77

1022

(40759836) Histone Ab [Presence] in Serum by Immunoblot

240

0.83

0.30

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.71

0.30

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

549

5329

1.03

0.30

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

206

0.82

0.29

2.3

2.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

249

0.84

0.29

1.2

u/ml

0.2

1.0

1.08

128

(3028026) IgM [Mass/volume] in Serum or Plasma

201

1914

1.05

0.28

2.1

1.4

g/l

1.6

1.1

1.41

186

1730

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

355

1.13

0.28

1.2

94.6

95.6

0.07

336

(3001186) Copper [Moles/volume] in Serum or Plasma

1.29

0.28

1.1

1.2

umol/l

18.2

15.6

1.42

(3006270) Folate [Moles/volume] in Blood

407

0.88

0.28

1.3

1.2

nmol/l

352.4

344.5

0.07

325

(3004451) EKG impression Narrative

233

1.16

0.27

1.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

110

1029

1.07

0.27

2.9

3.1

nmol/l

0.8

0.27

800

(3044927) Protein electrophoresis panel - Urine

511

0.90

0.27

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.23

0.27

1.0

—

(3020491) Glucose [Moles/volume] in Blood

300

0.87

0.26

1.5

2.4

mmol/l

7.1

6.9

0.14

199

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

243

1.15

0.26

1.2

1.5

umol/l

14.2

14.0

0.04

225

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

182

0.82

0.26

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

301

3121

0.96

0.26

3.3

3.8

ng/l

91.9

97.3

0.46

254

2619

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.68

0.26

1.8

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

138

0.80

0.25

2.0

1.8

ug/l

75.5

52.2

0.71

133

(4268621)

319

0.88

0.25

2.4

2.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.20

0.25

1.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

437

4495

0.97

0.24

2.0

2.5

ug/l

6.4

7.4

0.61

372

3908

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

202

0.84

0.24

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

0.85

0.24

1.4

1.3

nmol/l

1.1

1.2

0.30

175

(40768443) Skin Pathology biopsy report

150

1578

0.95

0.24

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

137

0.80

0.24

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

475

0.90

0.24

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

465

1.10

0.24

1.2

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

179

0.84

0.23

1.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

125

0.80

0.23

1.1

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

266

1.13

0.22

1.3

1.2

mmol/l

12.3

11.9

0.09

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.22

1.0

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.22

0.22

8.4

3.6

ug/min

70.2

44.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

244

2527

0.96

0.21

1.2

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.19

0.21

4.2

1.9

—

34.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.19

0.21

1.8

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.19

0.21

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.19

0.21

1.0

1.2

u/l

18.8

14.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

0.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.2

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

127

1334

0.95

0.21

2.7

1.4

g/l

37.0

37.6

0.51

103

1105

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(40757373) Influenza virus identified in Isolate

1.24

0.20

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

345

3353

1.03

0.20

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

934

0.94

0.20

3.8

3.7

mg/l

28.7

28.2

0.04

609

(3008295) Osmolality of Serum or Plasma

364

1.10

0.20

1.3

1.4

mosm/kgh2o

273.2

278.2

0.85

278

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

134

1278

1.05

0.20

1.7

1.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

653

0.93

0.18

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

217

0.87

0.18

3.1

4.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

109

1144

0.95

0.18

2.7

1.5

g/l

0.0

0.00

1040

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1061

10469

1.02

0.18

3.0

2.8

ug/l

0.8

0.7

1.01

747

7306

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

136

1415

0.96

0.16

2.8

1.5

g/l

0.7

0.5

0.47

115

1192

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

120

1252

0.96

0.16

2.9

1.5

g/l

0.0

0.70

106

1130

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

504

0.93

0.16

1.1

1.2

miu/ml

215.8

194.0

0.11

190

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1584

0.96

0.15

2.5

1.4

g/l

10.4

10.3

0.07

125

1301

(40768446) Kidney Pathology biopsy report

140

1.14

0.15

1.4

1.6

—

(44806420)

160

1.13

0.14

2.1

2.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

675

1.05

0.14

1.4

1.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

165

1701

0.97

0.14

2.6

1.4

g/l

3.7

3.9

0.58

114

1184

(3023511) Choriogonadotropin [Units/volume] in Urine

0.82

0.13

1.4

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.81

0.13

3.6

2.0

ug/l

1.0

—

(3011985) Renin [Units/volume] in Plasma

519

1.06

0.13

1.3

mu/l

49.0

65.9

0.63

460

(3016244) Insulin [Units/volume] in Serum or Plasma

128

0.86

0.13

2.5

3.0

mu/l

16.9

21.5

0.49

120

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

490

1.06

0.13

1.3

pmol/l

215.9

268.8

1.18

373

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

132

1.14

0.13

6.1

7.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

113

1.15

0.13

6.0

7.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1707

0.97

0.12

2.5

1.4

g/l

7.3

7.4

0.66

122

1231

(3019309) Folate [Moles/volume] in Red Blood Cells

914

9044

1.01

0.12

1.8

nmol/l

1129.6

1151.5

0.28

684

6766

(3016750) Collection duration of Urine

272

0.92

0.12

2.1

2.0

min

496.8

498.8

0.03

206

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1706

0.97

0.12

2.5

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

474

1.06

0.11

1.3

1.2

u/ml

3.2

5.1

1.09

213

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

113

1166

0.97

0.11

2.7

1.5

g/l

0.0

0.00

1045

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

125

0.88

0.10

4.2

1.7

212.1

158.7

1.01

116

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

351

0.94

0.10

1.2

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.14

0.10

2.4

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.14

0.10

2.4

2.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

453

0.95

0.10

1.2

106.4

114.4

1.15

406

(3029075) Extractable nuclear Ab panel - Serum

1.15

0.09

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

487

1.05

0.09

1.3

1.2

u/ml

4.5

0.01

146

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.04

0.09

1.8

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.09

0.08

14.0

12.8

mmol/l

5.2

5.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.82

0.08

1.8

1.1

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

146

1.10

0.08

8.0

6.1

71.7

71.1

0.04

125

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.09

0.08

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

460

1.04

0.08

1.2

1.5

u/ml

90.3

127.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.82

0.07

1.0

1.5

—

(4198724)

0.80

0.07

1.7

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

186

1.08

0.07

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.86

0.07

1.0

1.2

127.3

96.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.85

0.07

1.4

1.5

ng/l

103.4

136.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.85

0.06

2.4

1.8

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

187

1.07

0.06

1.2

1.3

mmol/l

6.1

6.2

0.11

175

(3004588) Protein electrophoresis panel - Serum or Plasma

299

3023

0.99

0.06

2.4

1.5

—

(3015183) Erythrocyte sedimentation rate

121

0.91

0.06

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

157

1593

0.98

0.05

2.6

1.4

g/l

3.1

3.0

0.31

117

1207

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

185

1825

1.01

0.05

3.1

2.9

pmol/l

4.3

4.4

0.45

168

1576

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

961

9566

1.01

0.05

1.7

pmol/l

23774043.3

28742704.3

0.11

795

7776

(21491868) Cryoglobulin [Mass/volume] in Serum

130

0.92

0.04

1.2

—

0.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

251

0.96

0.04

1.4

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

493

0.97

0.04

1.1

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

301

0.96

0.04

1.1

1.3

promille

0.8

1.2

0.82

229

(44813793)

220

0.95

0.03

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

458

1.03

0.03

1.2

u/ml

236.4

288.1

0.69

287

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.09

0.03

1.2

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

469

1.02

0.03

1.2

1.4

—

(3010503) CD19 cells [#/volume] in Blood

132

1.06

0.02

1.4

1.9

e9/l

0.1

1.58

126

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

182

1.04

0.02

1.2

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

451

1.02

0.02

1.2

1.3

nmol/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

418

0.98

0.01

1.1

1.2

mmol/l

7.6

7.8

0.11

290

(4306422)

467

0.98

0.01

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

613

1.01

0.01

1.5

1.3

u/l

18.1

8.5

3.02

491

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

184

1.03

0.00

1.1

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

144

0.97

0.00

1.0

1.2

—

(4024509)

410

1.00

0.00

1.7

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

115

0.96

0.00

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

526

1.01

0.00

1.2

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

418

1.00

0.00

3.0

3.7

—

(3000034) Microalbumin [Mass/volume] in Urine

458

1.00

0.00

3.5

3.0

mg/l

40.5

35.2

0.16

341

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

291

1.00

0.00

1.2

titre

74.0

163.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

164

0.98

0.00

1.3

1.1

—

(3017704) Immunofixation for Urine

245

0.98

0.00

1.3

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

3.8

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.1

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

121.4

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3001556) Androgen free Index in Serum or Plasma

0.00

0.0

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

0.96

0.00

1.0

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.98

0.00

1.1

1.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.00

0.00

1.2

1.7

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.92

0.00

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

1.9

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.4

—

0.2

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.94

0.00

5.3

7.4

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

3.9

—

18.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1167.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

250.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.00

0.00

1.2

1.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.93

0.00

1.1

1.4

—

1880525.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_RECTUM_EXALLC – Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

GWS hits: 12

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers) (C3_RECTUM_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints